Drugs Made In America Acquisition II Corp. Rights (DMIIR)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 08
0
0%
$
4.73M Market Cap
- P/E Ratio
- Div Yield
930 Volume
- Eps
$ 0.08
Previous Close Want to track DMIIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition II Corp. Rights Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| IH Isaac Haas Hbk Investments LP | 500,000 | $70,000 | $39,950 | -$30,050 | -42.93% |
| DB David Barlow Glazer Capital LLC | 1.9M | $265,999.92 | $151,801.93 | -$114,197.99 | -42.93% |
| MB Mitchel Bialek Css LLC/IL | 80,600 | $11,284 | $6,439.94 | -$4,844.06 | -42.93% |
| SK Steven Katznelson Radcliffe Capital Management LP | 575,000 | $80,500 | $45,942.5 | -$34,557.5 | -42.93% |
| VL Vincent Leva Linden Advisors LP | 899,899 | $125,985.86 | $71,901.93 | -$54,083.93 | -42.93% |
| BO Brian Oliveira Clear Street Group Inc. | 297,716 | $25,452.68 | $23,787.51 | -$1,665.17 | -6.54% |
| MCS Mercuria Capital Strategies LLC Mercuria Capital Strategies LLC | 750,000 | $60,000 | $59,925 | -$75 | -0.12% |
| AAS ABC Arbitrage SA ABC Arbitrage SA | 40,000 | $5,600 | $3,196 | -$2,404 | -42.93% |
2026 © Marketlog. All Rights Reserved.
